Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.

Viatris

Status and phase: Completed; Phase 4

Conditions: Seizures

Treatments: Drug: Pregabalin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00141427

A0081005

Details and patient eligibility

About

To assess the clinical improvement (change in seizure frequency), safety and tolerability of patients with partial seizures following adjunctive therapy of pregabalin BID in addition to existing standard AEDs.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male and female subjects with a diagnosis of partial epilepsy.
• 18 years and older.

Exclusion criteria

• Having a treatable cause of seizure.
• Having a progressive neurological or systemic disorder

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)